Coeptis Therapeutics, Inc.

Coeptis Therapeutics, Inc.

COEP
Coeptis Therapeutics, Inc.US flagNASDAQ Capital Market
16.40
USD
- -
- -
57.63MMarket Cap

Income Statement (USD)

APIChat
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
1
+ Sales & Services Revenue
- -
- -
- -
- -
- -
1
- Cost of Revenue
1
- -
- -
- -
- -
- -
+ Cost of Goods & Services
1
- -
- -
- -
- -
- -
Gross Profit
-1
- -
- -
- -
- -
1
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- Operating Expenses
6
14
34
21
10
14
+ Selling, General & Admin
6
14
34
14
7
12
+ Research & Development
- -
- -
- -
7
2
1
+ Other Operating Expense
- -
- -
- -
1
1
1
Operating Income (Loss)
-7
-14
-34
-21
-10
-13
- Non-Operating (Income) Loss
2
-1
3
- -
1
-1
+ Interest Expense, Net
- -
- -
- -
- -
- -
1
+ Interest Expense
- -
- -
- -
- -
- -
1
- Interest Income
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
2
-1
3
- -
1
-1
Pretax Income
-9
-13
-38
-21
-11
-12
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-9
-13
-38
-21
-11
-12
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
-1
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
-1
Income (Loss) Incl. MI
-9
-13
-38
-21
-10
-12
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-9
-13
-38
-21
-11
-12
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-9
-13
-38
-21
-11
-12
EBIT
-7
-14
-34
-21
-10
-13
EBITDA
-6
-14
-33
-20
-9
-12
EBITDA Margin (%)
-20,772.35
-18,131.36
- -
- -
- -
-867.24
EBITA
-7
-14
-34
-21
-10
-13
Gross Margin (%)
-3,034.54
100
- -
- -
- -
86.75
Operating Margin (%)
-21,823.77
-18,727.91
- -
- -
- -
-956.94
Profit Margin (%)
-29,765.89
-17,932.37
- -
- -
- -
-874.29
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
1
1
1
1
Basic Weighted Avg Shares
1
1
1
1
2
- -
Basic EPS, GAAP
-8.96
-13.16
-52.57
-16.56
-5.55
- -
Basic EPS from Cont Ops
-8.96
-13.16
-52.57
-16.56
-5.65
- -
Diluted Weighted Avg Shares
1
1
1
1
2
- -
Diluted EPS, GAAP
-8.96
-13.16
-52.57
-16.56
-5.55
- -
Diluted EPS from Cont Ops
-8.96
-13.16
-52.57
-16.56
-5.65
- -

Balance Sheet (USD)

APIChat
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
- -
2
4
2
1
7
+ Cash, Cash Equivalents & STI
- -
2
4
1
1
6
+ Cash & Cash Equivalents
- -
2
4
1
1
6
+ ST Investments
- -
- -
- -
- -
- -
1
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
4
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
-3
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
- -
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
5
4
3
8
9
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
6
8
+ LT Investments
- -
- -
- -
- -
6
8
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
5
4
3
2
1
+ Total Intangible Assets
- -
- -
- -
- -
1
1
+ Goodwill
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
1
1
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
5
4
3
2
- -
Total Assets
- -
7
8
5
9
16
+ Payables & Accruals
2
- -
- -
2
2
1
+ Accounts Payable
2
- -
- -
1
1
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
- -
- -
1
1
- -
+ ST Debt
2
2
2
1
1
- -
+ ST Borrowings
2
2
2
1
1
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
1
- -
- -
- -
1
1
+ Deferred Revenue
1
- -
- -
- -
- -
1
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
1
- -
Total Current Liabilities
5
3
2
3
5
2
+ LT Debt
- -
2
- -
- -
- -
- -
+ LT Borrowings
- -
2
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
1
1
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
1
1
- -
- -
Total Noncurrent Liabilities
- -
2
1
1
1
- -
Total Liabilities
5
4
3
4
5
2
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
9
30
71
92
103
127
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
9
30
71
92
103
127
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-14
-28
-66
-87
-98
-110
+ Other Equity
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-5
2
4
1
3
14
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
1
Total Equity
-5
2
4
1
4
14
Total Liabilities & Equity
- -
7
8
5
9
16
Shares Outstanding
1
1
1
2
2
6
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
Net Debt
2
2
-2
- -
1
-5
Net Debt to Equity
-35.55
80.3
-40.22
-42.28
20.82
-38.56
Tangible Common Equity Ratio
-1,711.69
34.74
56.26
17.81
39.74
86.31
Current Ratio
0.04
0.79
1.81
0.59
0.23
4.16
Cash Conversion Cycle
- -
- -
- -
- -
- -
-2,180.92

Cash Flow Statement (USD)

APIChat
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-9
-13
-38
-21
-11
-12
+ Depreciation & Amortization
- -
- -
1
1
1
1
+ Non-Cash Items
3
11
33
11
3
4
+ Stock-Based Compensation
- -
2
- -
- -
1
1
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
1
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
2
10
33
11
2
3
+ Chg in Non-Cash Work Cap
3
-3
-1
2
- -
-1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
2
-2
- -
2
- -
-1
+ Inc (Dec) in Other
- -
-1
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-3
-4
-4
-7
-7
-9
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
-2
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
-2
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
1
10
3
5
- -
8
+ Increase in Capital Stock
1
10
3
5
- -
8
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-2
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
2
-2
-2
-1
1
1
+ Cash From Debt
2
- -
- -
1
2
1
+ Repayments of Debt
- -
-2
-2
-1
-1
- -
+ Other Financing Activities
- -
- -
5
- -
4
5
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
3
8
5
5
6
14
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
2
2
-2
-1
5
EBITDA
-6
-14
-33
-20
-9
-12
EBITDA Margin (%)
-20,772.35
-18,131.36
- -
- -
- -
-867.24
Free Cash Flow
-3
-6
-4
-7
-7
-9
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-6
-6
-8
-5
-8
Free Cash Flow per Basic Share
-3.07
-6.1
-5.42
-5.64
-3.45
- -
Price/Free Cash Flow
-66.42
-74.62
-5.65
-2.78
-1.59
- -
Cash Flow to Net Income
0.34
0.33
0.1
0.34
0.62
0.72
Capital Expenditures
- -
-2
- -
- -
- -
- -